Health Innovative Immunotherapy Strategies Target Pancreatic Cancer Resistance Pancreatic ductal adenocarcinoma (PDAC) poses significant treatment challenges due to its immune-resistant characteristics and limited response to current therapies. In a recent discussion with... Editorial2 hours ago